Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2026-03-16 @ 8:30 PM
Study NCT ID:
NCT00788593
Status:
COMPLETED
Last Update Posted:
2014-03-12
First Post:
2008-11-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)
Sponsor:
Forest Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PR-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None